Effects of conformationally restricted synthetic retinoids on ovarian tumor cell growth

Journal of Cellular Biochemistry

Volumn 68, Issue 3, 1998, Pages 378-388

  Wu, Shujian ^a   Zhang, Dongmei ^a   Donigan, Anne ^a,c   Dawson, Marcia I ^b   Soprano, Dianne Robert ^a   Soprano, Kenneth J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SRI INTERNATIONAL   (United States)

^c Gwynedd Mercy University   (United States)

Author keywords

AHPN; Apoptosis; Growth suppression; Ovarian cancer; Retinoic acid receptors

Indexed keywords

RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH REGULATION; HUMAN; HUMAN CELL; OVARY TUMOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TRANSCRIPTION REGULATION;

EID: 0032030722     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980301)68:3<378::AID-JCB8>3.0.CO;2-R     Document Type: Article

References (45)

1. Berg K, Hansen MB, Nielsen SE (1990): A new sensitive bioassay for precise quantification of interferon activity as measured via the mitochondrial dehydrogenase function in cells (MTT-method). Acta Pathol Microbiol Immunol Scand 98:156-162.
2. Bernard BA, Bernardon J-M, Delescluse C, Martin B, Lenoir MC, Maignan J, Charpentier B, Pilgrim WR, Reichert U, Shroot B (1992): Identification of synthetic retinoids with selectivity for human nuclear retinoic receptor γ. Biochem Biophys Res Commun 186:977-983.
3. Chao W, Hobbs PD, Jong L, Zhang X, Zheng Y, Wu Q, Shroot B, Dawson MI (1997): Effects of receptor class-and sub-type-selective retinoids and an apoptosis-inducing retinoid on the adherent growth of the NIH:OVCAR-3 ovarian cancer cell line in culture. Cancer Lett 115:1-7.
4. Dawson MI, Hobbs PD, Derdzinski KA, Chao W-R, Frenking G, Loew GH, Jetten AM, Napoli JL, Williams JB, Sani BP, Wille JJ (1989): Effect of structural modifications in the C7-C11 region of the retinoid skeleton on biological activity in a series of aromatic retinoids. J Med Chem 32:1504-1517.
5. Dawson MI, Chao WR, Pine P, Jong L, Hobbs PD, Rudd CK, Quick TC, Niles RM, Zhang XK, Lombardo A, Ely KR, Shroot B, Fontana JA (1995a): Correlation of retinoid binding affinity to retinoic acid receptor Alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells. Cancer Res 55:4446-4451.
6. Dawson MI, Jong L, Hobbs PD, Camerson JF, Chao W-R, Pfahl M, Lee M-O, Shroot B, Pfahl M (1995b): Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity. J Med Chem 38:3368-3383.
7. Delia D, Aiello A, Formelli F, Fontanella E, Costa A, Miyashita T, Reed JC, Pierotti MA (1995): Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2. Blood 85:359-367.
8. Fanjul A, Dawson MI, Hobbs PD, Jong L, Cameron JF, Harlev E, Graupner G, Lu XP, Pfahl M (1994) A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 372:107-111.
9. Fountzilas G (1994): Retinoids in the management of head and neck cancer. An update. [Review.] J Chemother 6:127-138.
10. Grunt TW, Somay C, Pavelka M, Ellinger A, Dittrich E, Dittrich C (1991): The effects of dimethyl sulfoxide and retinoic acid on the cell growth and the phenotype of ovarian cancer cells. J Cell Sci 100:657-666.
11. Gudas L, Sporn MB, Roberts AB (1994): Cellular biology and biochemistry of the retinoids. In Sporn MB, Roberts AB, Goodman DS (eds): "The Retinoids." 2nd Ed. New York: Raven Press, pp 443-520.
12. Harant H, Korschineck I, Krupitza G, Fazeny B, Dittrich C Grunt T W (1993): Retinoic acid receptors in retinoid responsive ovarian cancer cell lines detected by polymerase chain reaction following reverse transcription. Br J Cancer 68:530-536.
13. Hembree JR, Agarwal C, Beard RL, Chandraratna RAS Eckert RL (1996): Retinoid X receptor retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein 3 in human ectocervical epithelial cells. Cancer Res 56:1794-1799.
14. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G Evans RM, Thaller C (1992): 9-cis retinoic acid is a high affinity ligand for the retinoic X receptor. Cell 68: 397-406.
15. Hofmann SL (1992): Retinoids - "differentiabon agents" for cancer treatment and prevention. [Review.] Am J Med Sci 304:202-213.
16. Kalemkerian GP, Slusher R, Ramalingam S, Gadgeel S, Mabry M (1995): Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. J Natl Cancer Inst 87:1674-1680.
17. Kastner P, Mark M, Chambon P (1995): Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83:859-869.
18. Lehmann JM, Dawson MI, Hobbs PD, Husmann M, Pfahl M (1991): Identification of retinoids with nuclear receptor subtype-selective activities. Cancer Res 51:4804-4809.
19. Lehmann JM, Jong L, Fanjul A, Cameron JF, Lu X-P, Haefner P, Dawson MI, Pfahl M (1992): Retinoids selective for retinoid V receptor response pathways. Science 258:1944-1946.
20. Leid M, Kastner P, Chambon P (1992b): Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biol Sci 17:427-433.
21. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, Speck J, Kratzeisen CI, Rosenberger M, Grippo JF (1992): 9-cis-retinoic acid sterioisomer binds and activates the nuclear receptor RXR-α. Nature 353:359-361.
22. Liu Y, Lee M-O, Wang H-G, Li Y, Hashimoto Y, Klaus M, Reed JC, Zhang X-K (1996): Retinoic acid receptor β Mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol 16:1138-1149.
23. Lotan R, Dawson MI, Zou C-C, Jong L, Lotan D, Zou C-P (1995): Enhanced efficacy of combinations of retinoic acid-and retinoid X receptor selective retinoids and α-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res 55:232-236.
24. Mangelsdorf DJ, Umesono K, Evans RM (1994): The retinoid receptors. In Sporn MB, Roberts AB, Goodman DS (eds): "The Retinoids." 2nd Ed. New York: Raven Press, pp 319-350.
25. Mangelsdorf D, Evans RM (1995): The RXR heterodimers and orphan receptors. Cell 83:841-850.
26. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg K, Kastner P, Mark M, Chambon P, Evans RM (1995): The nuclear receptor superfamily: The second decade. Cell 83:835-839.
27. Martin SJ, Bradley JG, Cotter TG (1990): HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin Exp Immunol 79:448-453.
28. Means AL, Gudas LJ (1995): The roles of retinoids in vertebrate development. Annu Rev Biochem 64:201-233.
29. McBurney MW, Costa S, Pratt MA (1993): Retinoids and cancer: A basis for differentiation therapy. [Review.] Cancer Invest 11:590-598.
30. Nagata S (1997) Apoptosis by death factor. Cell 88:355-365.
31. Nagy L, Thomazy VA, Shipley GL, Fesues L, Lamph W, Heyman RA, Chandraratna R, Davies P (1995): Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol Cell Biol 15:3540-3551.
32. Pena A, Reddy CD, Wu S, Hickok N, Reddy EP, Soprano DR, Soprano KJ (1993): Regulation of human ornithine decarboxylase expression by the c-myc/max protein complex. J Biol Chem 268:27277-27285.
33. Reynolds JE, Yang T, Qian L P, Jenkinson J d, Zhou P, Eastman A, Craig R W (1994): MCL-1, a member of the Bcl-2 family, delays apoptosis induced by c-myc overexpression in Chinese hamster ovary cells. Cancer Res 54:6348-6352.
34. Roy DY, Taneja R, Chambon P (1995): Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RARα)-, RARβ-, or RARγ-selective ligand in combination with a retinoid X receptor-specific ligand. Mol Cell Biol 15:6481-6487.
35. Salgame P, Varadhachary AS, Primiano L, Fincke JE, Muller S, Monestier M (1997): An ELISA for detection of apoptosis. Nucleic Acids Res 25:680-681.
36. Shao ZM, Dawson MI, Li XS, Rishi AK, Sheikh MS, Han QX, Ordonez JV, Shroot B, Fontana JA (1995): p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 11:493-504.
37. Sheikh MS, Shao ZM, Li XS, Dawson M, Jetten AM, Wu S, Conley BA, Garcia M, Rochefort H, Fontana JA (1994): Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids. J Biol Chem 269:21440-21447.
38. Soprano DR, Chen LX, Wu S, Donigan AM, Borghaei RC, Soprano KJ (1996): Overexpression of both RAR and RXR restores AP-1 repression in ovarian adenocarcinoma cells resistant to retinoic acid-dependent growth inhibition. Oncogene 12:577-584.
39. Supino R, Crosti M, Clerici M, Warlters A, Cleris L, Zunino F, Formelli F (1996): Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression. Int J Cancer 65:491-497.
40. Taneja R, Bouillet P, Boylan JF, Gaub MP, Roy B, Gudas LJ, Chambon P (1995): Reexpression of retinoic acid receptor (RAR)gamma or overexpression of RARalpha or RARbeta in RARgamma-null F9 cells reveals a partial functional redundancy between the three RAR types. Proc Natl Acad Sci USA 92:7854-7858.
41. van der Leede BJ, Folkers GE, van den Brink CE, van der Saag PT, van der Burg B (1995): Retinoic acid receptor alpha 1 isoform is induced by estradiol and confers retinoic acid sensitivity in human breast cancer cells. Mol Cell Endocrinol 109:77-86.
42. White E (1996) Life, death and the pursuit of apoptosis. Genes Dev 10:1-15.
43. Wu S, Donigan A, Platsoucas CD, Jung W, Soprano DR, Soprano KJ (1997a): All-trans-retinoic acid blocks cell cycle progression of human ovarian adenocarcinoma cells at late G1. Exp Cell Res 232:277-286.
44. Wu S, Zhang Z-P, Soprano DR, Soprano KJ (1997b): Reduction of both RAR and RXR levels is required to maximally alter sensitivity of CA)V-3 ovarian tumor cells to growth suppression by all-trans-retinoic acid. Exp Cell Res (in press).
45. Zhang LX, Mills KJ, Dawson MI, Collins SJ, Jetten AM (1995): Evidence for the involvement of retinoic acid receptor RARalpha-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids. J Biol Chem 270:6022-6029.